Oncology
From promise to practice: What must happen next for genetic ...
The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.
Digital
Changing Faces: Digital and supplier, March 2026
Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
R&D
The conflict in the Middle East is exposing dangerous prepar...
If the conflict persists, the risk of widespread medicine shortages becomes increasingly real.
Digital
From static documents to strategic capability: The case for ...
Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.
R&D
LSX2026: Endogenous tissue restoration in vascular disease –...
Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
